Fennec Pharmaceuticals(FRA) RV41

Market Cap€350.67M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€10.50

-0.94%

-0.10Today

Fennec Pharmaceuticals Financials at a Glance

Market Cap

€350.67M

Revenue (TTM)

€50.79

Net Income (TTM)

-€3.10

EPS (TTM)

-€0.11

P/E Ratio

-90.99

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Price

€10.50

Volume

Open

€9.95

Price

€10.50

Volume

Open

€9.95

Previous Close

€10.50

Daily Range

€9.95 - €10.50

52-Week Range

€4.80 - €11.10

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Price

€10.50

Volume

Open

€9.95

Previous Close

€10.50

Daily Range

€9.95 - €10.50

52-Week Range

€4.80 - €11.10

Estimated Earnings Date

N/A

RV41 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fennec Pharmaceuticals

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jeffrey S Hackman

Website

www.fennecpharma.com

RV41 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-20.13%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.10%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€350.67M

Shares Outstanding

35.07M

Volume

Avg. Volume

42.242

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Fennec Pharmaceuticals Performance Analysis

Fennec Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 1,460,549	N/A
2023	2023-12-31	EUR 19,657,472	1245.9%
2024	2024-12-31	EUR 43,947,866	123.6%
2025	2025-12-31	EUR 39,555,974	-10.0%

Fennec Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.86	52.2%
2023	2023-12-31	EUR -0.56	-35.0%
2024	2024-12-31	EUR -0.01	-97.4%
2025	2025-12-31	EUR -0.30	1940.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€15.37

+1.8%

Gross Profit

€14.75

+1.9%

Gross Margin

95.97%

+1.1%

Market Cap

€350.67M

N/A

Market Cap/Employee

€9.13

N/A

Employees

N/A

Net Income

€1.70

-0.6%

EBITDA

€1.52

-0.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€36.08

+15.1%

Total Debt

€0.00

+0.0%

Accounts Receivable

€20.35

+1.4%

Inventory

€2.08

+1.1%

Long Term Debt

€0.00

+0.0%

Short Term Debt

€0.00

N/A

Return on Assets

-5.93%

+0.3%

Return on Invested Capital

-62.42%

+0.9%

Free Cash Flow

€0.05

-0.0%

Operating Cash Flow

€0.05

-0.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About RV41

What is the current price of Fennec Pharmaceuticals?

Fennec Pharmaceuticals is trading at €10.50 per share.

What is the 52-week range for Fennec Pharmaceuticals?

Over the past 52 weeks, Fennec Pharmaceuticals has traded between €4.80 and €11.10.

How much debt does Fennec Pharmaceuticals have?

As of the most recent reporting period, Fennec Pharmaceuticals reported total debt of €0.00.

How much cash does Fennec Pharmaceuticals have on hand?

Fennec Pharmaceuticals reported €36.08M in cash and cash equivalents in its most recent financial results.

What is Fennec Pharmaceuticals’s dividend yield?

Fennec Pharmaceuticals does not currently have a dividend yield.

Fennec Pharmaceuticals(FRA) RV41

Fennec Pharmaceuticals Financials at a Glance

RV41 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Fennec Pharmaceuticals

RV41 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Fennec Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RV41

What is the current price of Fennec Pharmaceuticals?

What is the 52-week range for Fennec Pharmaceuticals?

How much debt does Fennec Pharmaceuticals have?

How much cash does Fennec Pharmaceuticals have on hand?

What is Fennec Pharmaceuticals’s dividend yield?

Premium Investing Services